Surgery for pancreatic tumors in the midst of COVID-19 pandemic

作     者：Hiroyuki Kato Yukio Asano Satoshi Arakawa Masahiro Ito Norihiko Kawabe Masahiro Shimura Chihiro Hayashi Takayuki Ochi Hironobu Yasuoka Takahiko Higashiguchi Yuka Kondo Hidetoshi Nagata Akihiko Horiguchi 

作者机构：Department of Gastroenterological SurgeryFujita Health University School of Medicine Bantane HospitalNagoya 454-8509Japan 

出 版 物：《World Journal of Clinical Cases》 (世界临床病例杂志)

年 卷 期：2021年第9卷第18期

页      面：4460-4466页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：COVID-19 Pancreatic ductal adenocarcinoma Surgical treatment Pancreatic tumor Pandemic National comprehensive cancer network resectability criteria 

摘      要：The spread of the new coronavirus(COVID-19)infection in 2020 has had a significant impact on the treatment of cancer *** the COVID-19 pandemic,the biggest challenge for pancreatic surgeons is the difficulty in providing oncological *** this review article,from the standpoint of surgeons,we explain the concept of triaging of patients with pancreatic tumors under the COVID-19 pandemic,and the actual impact of COVID-19 on the treatment of patients with pancreatic *** most vital points in selecting the best therapeutic approach for patients with pancreatic tumors during this pandemic are(1)Oncologists need to tailor the treatment plan based on the COVID-19 phase,tumor malignant potential,and patients’comorbidities;and(2)Optimal treatment for pancreatic cancer should be planned according to the condition of each patient and tumor resectability based on national comprehensive cancer network resectability *** choose the best therapeutic approach for patients with pancreatic tumors during this pandemic,we need to tailor the treatment plan based on elective surgery acuity scale(ESAS).Newly established ESAS for pancreatic tumor and flowchart indicating the treatment strategy of pancreatic cancer,are feasible to overcome this situation.